TRPA1: An asthma target with a zing.
Publication
, Journal Article
Jordt, S-E
Published in: J Exp Med
April 5, 2021
Asthma therapy has advanced remarkably; however, a significant number of patients respond poorly to current interventions. Balestrini et al. (2021. J. Exp. Med.https://doi.org/10.1084/jem.20201637) advance the concept that sensory nerves control inflammation in asthma, demonstrating that a novel inhibitor of TRPA1, a nerve receptor for irritants and reactive endogenous mediators, suppresses inflammation and airway smooth muscle contraction in several preclinical species.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Exp Med
DOI
EISSN
1540-9538
Publication Date
April 5, 2021
Volume
218
Issue
4
Location
United States
Related Subject Headings
- TRPA1 Cation Channel
- Inflammation
- Immunology
- Humans
- Asthma
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jordt, S.-E. (2021). TRPA1: An asthma target with a zing. J Exp Med, 218(4). https://doi.org/10.1084/jem.20202507
Jordt, Sven-Eric. “TRPA1: An asthma target with a zing.” J Exp Med 218, no. 4 (April 5, 2021). https://doi.org/10.1084/jem.20202507.
Jordt S-E. TRPA1: An asthma target with a zing. J Exp Med. 2021 Apr 5;218(4).
Jordt, Sven-Eric. “TRPA1: An asthma target with a zing.” J Exp Med, vol. 218, no. 4, Apr. 2021. Pubmed, doi:10.1084/jem.20202507.
Jordt S-E. TRPA1: An asthma target with a zing. J Exp Med. 2021 Apr 5;218(4).
Published In
J Exp Med
DOI
EISSN
1540-9538
Publication Date
April 5, 2021
Volume
218
Issue
4
Location
United States
Related Subject Headings
- TRPA1 Cation Channel
- Inflammation
- Immunology
- Humans
- Asthma
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences